Marker Therapeutics Inc
NASDAQ:MRKR

Watchlist Manager
Marker Therapeutics Inc Logo
Marker Therapeutics Inc
NASDAQ:MRKR
Watchlist
Price: 1.435 USD 3.24% Market Closed
Market Cap: 23.9m USD

Wall Street
Price Targets

MRKR Price Targets Summary
Marker Therapeutics Inc

Wall Street analysts forecast MRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRKR is 8.33 USD with a low forecast of 4.04 USD and a high forecast of 13.125 USD.

Lowest
Price Target
4.04 USD
182% Upside
Average
Price Target
8.33 USD
480% Upside
Highest
Price Target
13.125 USD
815% Upside
Marker Therapeutics Inc Competitors:
Price Targets
603087
Gan & Lee Pharmaceuticals
4% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
49% Upside
PTCT
PTC Therapeutics Inc
6% Upside
MDXG
MiMedx Group Inc
80% Upside
AUPH
Aurinia Pharmaceuticals Inc
5% Upside
ADMA
ADMA Biologics Inc
36% Upside
SLNO
Soleno Therapeutics Inc
143% Upside
BAVA
Bavarian Nordic A/S
35% Upside

Revenue
Forecast

Revenue Estimate
Marker Therapeutics Inc

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

N/A
Past Growth
109%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRKR's stock price target?
Price Target
8.33 USD

According to Wall Street analysts, the average 1-year price target for MRKR is 8.33 USD with a low forecast of 4.04 USD and a high forecast of 13.125 USD.

What is Marker Therapeutics Inc's Revenue forecast?
Projected CAGR
109%

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

Back to Top